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chizophrenia affects approximately 1% of the population, with presentation occurring most commonly in individuals aged 15 to 35 years. 1, 2 This mental disease appears to affect both male and female individuals equally. 1 There is a genetic correlation, but no single gene has been identified as a cause of the disease. 3 Rather, current theories propose that schizophrenia is caused by multiple genetic mutations that result in a multifaceted clinical presentation and course. 3 Approximately 10% of individuals with schizophrenia commit suicide, and substance abuse is common as these individuals attempt to self-medicate. 2 It is common practice for schizophrenia to be managed with antipsychotic (neuroleptic) medications to control highly frequent auditory hallucinations. Antipsychotic medications, however, are associated with tardive dyskinesia, or the involuntary contracture of muscles. This adverse reaction is more likely to occur in patients who receive first generation, or "typical," antipsychotics such as haloperidol. 3 Tardive dyskinesia is purportedly a result of dopaminergic hypersensitivity 1, 3 secondarily causing a cholinergic deficiency. 3 The orofacial muscles are most commonly affected, resulting in repetitive chewing or tongue-smacking movements. 4 Unwanted movements are not limited to the face, however; they can occur in the cranium, spine, thorax, and upper and lower limbs. Individuals with the classic orofacial involvement may be unaware of these movements, but others often find them to be embarrassing and disabling. 4 Time from the start of antipsy- with accompanying medications. In July 2012, the chotic medication to the onset of tardive dyskinesia is generally greater than 6 weeks. 4 When administering antipsychotic medications, physicians should monitor patients for early signs of tardive dyskinesia because advanced cases of the disease are difficult to reverse. 3 It is estimated that even after the offending antipsychotic medication is discontinued, approximately 50% of patients will continue to experience chronic symptoms of tardive dyskinesia. 4 At the first sign of tardive dyskinesia, physicians should switch to an atypical antipsychotic with a lower risk profile such as quetiapine fumarate or clozapine. 3 Other pharmacologic management options include avoidance of centrally acting anticholinergics (particularly antiparkinsonisms and tricyclic antidepressants), 3 addition of benzodiazapines, 3 and the dopamine-depleting agent tetrabenzanine. 4, 5 In addition to these pharmacologic treatment strategies, the Dystonia Medical Research Foundation also lists the following: botulinum toxin injections; physical, occupational, and speech therapies; surgical intervention; and complementary therapies (eg, biofeedback, yoga). 5 The Foundation did not list manipulative treatment as a therapy option for patients with dystonia.
5
A literature review for manipulative management of tardive dyskinesia yielded a single case report in which chiropractic manipulation was used to manage pain associated with tardive dyskinesia. 6 It is understood that these treatments are not used to cure tardive dyskinesia but instead are used palliatively to improve the patient's pain and overall quality of life. The following case is an example of how osteopathic manipulative treatment (OMT) can be used to reduce pain and improve quality of life in a patient with tardive dyskinesia.
Report of Case
In July 2012, a 29-year-old woman presented to her family physician for ongoing management of schizophrenia; she had been receiving care at the same family
CASE REPORT
The response; according to the case report, the patient continued to follow up with palliative care for her chronic tardive dyskinesia. 6 Although we were unable to follow up with the patient in the present case, we believe it is likely she would have continued to benefit from ongoing OMT sessions. However, it would be imprudent to assume that 1 treatment would be sufficient for a chronic neuromusculoskeletal condition such as tardive dyskinesia, which is likely to result in repetitive somatosomatic reflexive spinal dysfunction.
Conclusion
Although it is unlikely that spinal manipulation would 
